Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN71,9471,952,98
Msft0,13
Nokia4,374,520,65
IBM-1,94
Mercedes-Benz Group AG50,9350,950,39
PFE-3,00
10.05.2025 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 05.05.2025 17:10:12
KIRIN BREWERY (2503.F, Frankfurt)
Závěr k 9.5.2025 Změna (%) Změna (EUR) Objem obchodů (EUR)
13,20 0,00 0,00 2 600
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 10.05.2025
Popis společnosti
Obecné informace
Název společnostiKirin Holdings Co Ltd
Ticker2503
Kmenové akcie:Ordinary Shares
RIC2503.T
ISINJP3258000003
Poslední známé roční výsledky31.12.2024
Poslední známé čtvrtletní výsledky31.12.2024
Počet zaměstnanců k 31.12.2024 31 934
Akcie v oběhu k 31.12.2024 809 994 362
MěnaJPY
Kontaktní informace
UliceNakano Central Park South
MěstoNAKANO-KU
PSČ164-0001
ZeměJapan
Kontatní osobaHidefumi Matsuo
Funkce kontaktní osobyDirector of Finance Strategy
Telefon81 368 377 000
Fax81355403547
Kontatní telefon810 368 377 015

Business Summary: Kirin Holdings Co Ltd is a Japan-based company mainly engaged in the integrated beverage business and the pharmaceutical business. The Company operates in four business segments. The Domestic Beer and Spirits segment is engaged in the manufacture and sale of beer, low-malt beer, new genre products, wines and other liquor products in Japan. The Domestic Beverages segment is engaged in the manufacture and sale of soft drinks in Japan. The Oceania Alcoholic Beverages segment manufactures and sells beer, Western-style liquors in Oceania and other regions. The Pharmaceuticals segment is engaged in the manufacture and sale of pharmaceutical products. The Company is also engaged in the domestic wine business, North American beverage business, and the biochemical business.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2024, Kirin Holdings Co Ltd revenues increased 10% to Y2.338T. Net income decreased 48% to Y58.21B. Revenues reflect Health science segment increase of 70% to Y175.26B, Medicine segment increase of 12% to Y495.3B, America segment increase of 17% to Y631.04B, Other segment increase of 31% to Y258.64B. Net income was offset by Loss on Business Restructure increase from Y2.78B to Y37.4B (expense).
Odvětvová klasifikace
TRBC2009Beverages - Brewers
TRBC2012Brewers (NEC)
RBSS2004Beverages - Brewers
MGINDUSTRYBeverages (Alcoholic)
MGSECTORConsumer/Non-Cyclical
NAICSBreweries
NAICSWineries
NAICSDistilleries
NAICSSoft Drink Manufacturing
NAICSFluid Milk Manufacturing
NAICSPharmaceutical Preparation Manufacturing
NAICSOffices of Other Holding Companies
NAICS2007Breweries
NAICS2007Wineries
NAICS2007Distilleries
NAICS2007Soft Drink Mfg
NAICS2007Fluid Milk Mfg
NAICS2007Pharmaceutical Preparation Mfg
NAICS2007Offices of Other Holding Companies
NAICS1997Breweries
NAICS1997Wineries
NAICS1997Distilleries
NAICS1997Soft Drink Manufacturing
NAICS1997Fluid Milk Manufacturing
NAICS1997Pharmaceutical Preparation Manufacturing
NAICS1997Offices of Other Holding Companies
SICMalt Beverages
SICWines, Brandy, And Spirits
SICDistilled And Blended Liquors
SICBottled And Canned Soft Drinks
SICFluid Milk
SICPharmaceutical Preparations
SICHolding Companies, Nec



  • Poslední aktualizace: 10.05.2025
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the Board, Chief Executive Officer, Representative DirectorYoshinori Isozaki6628.03.2024
President, Chief Operating Officer, Representative DirectorTakeshi Minakata6228.03.2024
Vice President, DirectorJunko Tsuboi6128.03.2024
Managing Executive Officer, DirectorShinjiro Akieda5928.03.2024
Managing Executive Officer, Chief Director of Health Science Business, DirectorToru Yoshimura5928.03.2024
Managing Executive Officer, Director of CSV StrategyHiroshi Fujikawa-28.03.202420.03.2022
Managing Executive Officer, President of SubsidiaryKoji Fukada-01.01.202401.01.2021
Managing Executive Officer, President of SubsidiaryHideki Horiguchi-01.01.201901.01.2019
Managing Executive Officer, President of SubsidiaryKazuhiro Inoue-28.03.202428.03.2024
Managing Executive OfficerAkiyoshi Iwasaki-28.03.202430.03.2021